Zu "1640282-42-3" wurden 2 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Zunsemetinib
Zunsemetinib

Artikelnummer: Cay41863-1

Zunsemetinib is a p38alpha MAPK inhibitor biased toward MAPK-activated protein kinase 2 (MK2). It selectively inhibits p38alpha MAPK-dependent activation of MK2 over p38alpha MAPK-dependent activation of MK5, also known as p38-regulated/activated protein kinase (PRAK), and p38alpha MAPK-dependent activation of...
Schlagworte: ATI-450, CDD-450,...
Anwendung: MK2-biased p38alpha MAPK inhibitor
CAS 1640282-42-3
MW: 513.9 D
ab 217,00 €
Bewerten
Zunsemetinib
Zunsemetinib

Artikelnummer: TGM-T39126-10mg

Description: Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38alpha mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis. Target: MAPK. Smiles:...
Schlagworte: ATI-450 , CDD-450
Anwendung: Targets mitogen-activated protein kinase-activated protein kinase 2 [EC:2.7.11.1] (MAPKAPK2)
CAS 1640282-42-3
MW: 513.92 D
ab 262,00 €
Bewerten